Global Diagnostic Imaging Market to Reach $34.6 Billion by 2028
Global Diagnostic Imaging Market to Reach $34.6 Billion by 2028
The diagnostic imaging market is expected to reach $34.6 billion by 2028. We conducted this research in response to a significant commitment received from an emerging hospital chain in the UAE.
The global diagnostic imaging market, valued at $26.5 billion in 2023, is projected to reach $34.6 billion by 2028, growing at a CAGR of 5.5%.
The market is driven by an aging population and the rising prevalence of chronic diseases such as cancer and cardiovascular conditions. Key growth factors include increasing funding, the adoption of teleradiology, and technological advancements. However, the high cost of diagnostic systems and the shortage of skilled professionals pose significant challenges.
Emerging economies offer substantial growth opportunities due to the increasing prevalence of disease. Major market players include GE Healthcare, Siemens Healthineers, and Philips, with North America currently holding the largest market share.
A detailed analysis of regional developments will follow shortly.
www.eXinvest.ae
Latest
-
-
23. January 2026Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
24. December 2025
eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
-
20. December 2025eXinvest of Emirates Supports Pharma & Biotech with Comprehensive Outsourced Drug Discovery Services
-
15. December 2025eXinvest of Emirates Delivers Tailor-Made Clean Rooms Across Medical, Pharmaceutical, and Industrial Sectors
-
13. February 2026WHX 2026 Highlights UAE as a Global Hub for Healthcare and Pharmaceuticals: eXinvest and Finchemo Engage with Industry Leaders
-
23. January 2026Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
24. December 2025
eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
-
20. December 2025eXinvest of Emirates Supports Pharma & Biotech with Comprehensive Outsourced Drug Discovery Services
-
15. December 2025eXinvest of Emirates Delivers Tailor-Made Clean Rooms Across Medical, Pharmaceutical, and Industrial Sectors